The optimal approach to treatment in the post-CDK4/6 inhibitor setting remains undefined, but multiple strategies have ...

In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen receptor antagonist and degrader (SERD), when given as an adjuvant therapy ...

Highlights of the conference coverage from the 2025 European Society of Medical Oncology (ESMO) Congress included content on ...

At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen ...

Endocrine-disrupting chemicals (EDCs) are a class of chemicals that mimic, block or interfere with the production, metabolism or action of hormones in the body. As EDCs are ubiquitous in our ...

Diagnosing an endocrine disorder can be challenging because symptoms often mimic those of other conditions, and treatment plans can be complex. That’s why people with an endocrine disease need to see ...

Sacituzumab govitecan failed to extend PFS in patients with hormone receptor-positive, HER2-negative breast cancer following endocrine therapy, according to data from San Antonio Breast Cancer ...

At the San Antonio Breast Cancer Symposium, researchers reported that real-time monitoring with smart pill bottles ...

Researchers report links between third-trimester exposure to endocrine disruptors and higher behavioural risk scores in early childhood.

Endocrine therapy is a way of treating conditions such as cancer using hormones. Also known as hormone therapy, it involves adjusting the levels of certain hormones, such as testosterone, estrogen, ...

Endocrine disruptors are substances that interfere with the endocrine system. They are present in products such as food and beverage packaging, cosmetics, and flame-retardant chemicals. The endocrine ...